HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 90 filers reported holding HEALTH CATALYST INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,146,000,000 | +10.3% | 39,302 | -1.1% | 0.02% | +19.0% |
| Q1 2020 | $1,039,000,000 | -33.1% | 39,750 | -11.2% | 0.02% | -52.3% |
| Q4 2019 | $1,553,000,000 | -9.0% | 44,750 | -17.0% | 0.04% | -6.4% |
| Q3 2019 | $1,706,000,000 | – | 53,930 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
| Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
| First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
| Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
| Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
| CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
| Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
| Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
| Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |